Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma (2021)
- Authors:
- Tesileanu, C. Mircea S.
- Van den Bent, Martin
- Sanson, Marc
- Wick, Wolfgang
- Brandes, Alba
- Clement, Paul M.
- Erridge, Sara C.
- Vogelbaum, Michael A.
- Nowak, Anna
- Baurain, Jean
- Mason, Warren P.
- Wheeler, Helen
- Chinot, Olivier L.
- Gill, Sanjeev
- Griffin, Matthew
- Rogers, Leland
- Taal, Walter
- Rudà, Roberta
- Weller, Michael
- McBain, Catherine
- Linde, Myra E. van
- Sabedot, Thais S.
- Hoogstrate, Youri
- Deimling, Andreas von
- Heer, Iris de
- IJcken, Wilfred F. J. van
- Brouwer, Rutger W. W.
- Aldape, Kenneth
- Jenkins, Robert B.
- Dubbink, Hendrikus
- Kros, Johan M.
- Wesseling, Pieter
- Cheung, Kin Jip
- Golfinopoulos, Vassilis
- Baumert, Brigitta
- Gorlia, Thierry
- Noushmehr, Houtan
- French, Pim
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1093/neuonc/noab088
- Subjects: NEOPLASIAS CEREBRAIS; METILAÇÃO DE DNA; GLIOMA; MUTAÇÃO; ESTUDOS PROSPECTIVOS
- Keywords: IDH mutant; DNA methylation profiling; Anaplastic glioma; Patient prognostication
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Neuro-Oncology
- ISSN: 1522-8517
- Volume/Número/Paginação/Ano: v. 23, n. 9, p. 1547-1559, 2021
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, v. 23, n. 9, p. 1547-1559, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab088. Acesso em: 06 maio 2026. -
APA
Tesileanu, C. M. S., Van den Bent, M., Sanson, M., Wick, W., Brandes, A., Clement, P. M., et al. (2021). Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, 23( 9), 1547-1559. doi:10.1093/neuonc/noab088 -
NLM
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2026 maio 06 ] Available from: https://doi.org/10.1093/neuonc/noab088 -
Vancouver
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2026 maio 06 ] Available from: https://doi.org/10.1093/neuonc/noab088 - TCGA workflow: analyze cancer genomics and epigenomics data using bioconductor packages [version 2; referees: 1 approved, 2 approved with reservations]
- The cancer genome atlas pan-cancer analysis project
- The somatic genomic landscape of glioblastoma
- Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1
- Mais um passo da ciência. [Depoimento a Rosemeire Soares Talamone]
- Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs
- GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
- Molecular patterns at regulatory elements diferentially methylated in glioma
- DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003074685.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
